ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1004

Single-Cell Analysis Reveals Tissue Resident Memory T Cells Heterogeneity in the Joint

Yang Yang1, Yusuke Miyashita2, Madison Mangin3, Kellen Winden1, Peter Nigrovic2 and Margaret Chang1, 1Boston Children's Hospital, Boston, MA, 2Boston Children's Hospital, Brookline, MA, 3Boston Children's Hospital, St Simons Island, GA

Meeting: ACR Convergence 2025

Keywords: Bioinformatics, Gene Expression, immunology, rheumatoid arthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0978–1006) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint-specific memory, the phenomenon in which arthritis repeatedly flares in the same joints. We previously demonstrated that CD8 synovial resident memory T (TRM) cells persist in arthritic joints and mediate joint-specific memory. There is increasing recognition of diversity among TRM cells with distinct functional subsets described across tissues and diseases. Here, we evaluated the heterogeneity of CD8 TRM cells within arthritic synovium in humans and mice and investigated their developmental precursors.

Methods: We evaluated the gene expression profiles of memory T cells isolated from human RA synovium through 10x single-cell RNA sequencing. As we previously demonstrated CD8 TRM cells to be important for joint specific memory, we further evaluated subclusters of CD8 memory T cells from the synovium using Seurat and weighted gene co-expression network analysis packages. Cell clusters were annotated by the presence of known marker genes and comparison to published TRM gene expression signatures. We further evaluated the gene expression profiles of CD8 T cells isolated from the synovium of a mouse model of arthritis of flare and remission. CD8 T cells were isolated from the synovium at several time points across the course of arthritis through acute joint inflammation and remission and sequenced by 10x single-cell RNA sequencing. Synovial TRM cells were identified through transcriptomic profiles and presence in synovium during remission. Subclusters of CD8 TRM cells were further refined, and trajectory of analysis and cell ancestry of these synovial CD8 TRM cell clusters were computed with the Waddington Optimal Transport and Pseudotime analysis packages. We further confirmed the developmental progenitors of these TRM cells using human synovial organoids.

Results: We identified diversity among CD8 memory T cells in human RA synovium, including several subclusters of cells exhibiting transcriptomic profiles consistent with TRM. Gene Ontology enrichment analysis of highly expressed genes among TRM subclusters reveals pathways in T cell differentiation, granzyme-mediated programmed cell death signaling, and negative regulation of T cell apoptosis, suggesting distinct functions in cytotoxicity and tissue-adaptive programming. We identified similar TRM subpopulations in the synovium of murine arthritis during remission. Trajectory analysis revealed different timing in the emergence of these TRM subpopulations during arthritis, further implicating distinct roles in disease.

Conclusion: Our findings reveal heterogeneity within CD8 TRM cells in both murine and human synovial tissue. This diversity in function and timing of these TRM subpopulations suggests different roles in arthritis pathogenesis.


Disclosures: Y. Yang: None; Y. Miyashita: None; M. Mangin: None; K. Winden: None; P. Nigrovic: Alkermes, 2, Apollo, 2, Bristol-Myers Squibb(BMS), 5, Century, 2, Edelweiss Therapeutics, 11, Merck, 2, Monte Rosa, 2, Novartis, 2, Pfizer, 2, 5; M. Chang: None.

To cite this abstract in AMA style:

Yang Y, Miyashita Y, Mangin M, Winden K, Nigrovic P, Chang M. Single-Cell Analysis Reveals Tissue Resident Memory T Cells Heterogeneity in the Joint [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/single-cell-analysis-reveals-tissue-resident-memory-t-cells-heterogeneity-in-the-joint/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-analysis-reveals-tissue-resident-memory-t-cells-heterogeneity-in-the-joint/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology